Author
Listed:
- Giovanni Giuseppe Giobbe
(University College London GOS Institute of Child Health)
- Claire Crowley
(University College London GOS Institute of Child Health)
- Camilla Luni
(ShanghaiTech University)
- Sara Campinoti
(University College London GOS Institute of Child Health
the Francis Crick Institute)
- Moustafa Khedr
(University College London GOS Institute of Child Health)
- Kai Kretzschmar
(Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht)
- Martina Maria De Santis
(University College London GOS Institute of Child Health)
- Elisa Zambaiti
(University College London GOS Institute of Child Health)
- Federica Michielin
(University College London GOS Institute of Child Health)
- Laween Meran
(University College London GOS Institute of Child Health
the Francis Crick Institute)
- Qianjiang Hu
(ShanghaiTech University)
- Gijs van Son
(Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht)
- Luca Urbani
(University College London GOS Institute of Child Health)
- Anna Manfredi
(Telethon Institute of Genetics and Medicine (TIGEM))
- Monica Giomo
(University of Padova)
- Simon Eaton
(University College London GOS Institute of Child Health)
- Davide Cacchiarelli
(Telethon Institute of Genetics and Medicine (TIGEM))
- Vivian S. W. Li
(the Francis Crick Institute)
- Hans Clevers
(Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht
Princess Máxima Center (PMC) for Pediatric Oncology)
- Paola Bonfanti
(University College London GOS Institute of Child Health
the Francis Crick Institute)
- Nicola Elvassore
(University College London GOS Institute of Child Health
ShanghaiTech University
University of Padova)
- Paolo De Coppi
(University College London GOS Institute of Child Health
Great Ormond Street Hospital)
Abstract
Organoids have extensive therapeutic potential and are increasingly opening up new avenues within regenerative medicine. However, their clinical application is greatly limited by the lack of effective GMP-compliant systems for organoid expansion in culture. Here, we envisage that the use of extracellular matrix (ECM) hydrogels derived from decellularized tissues (DT) can provide an environment capable of directing cell growth. These gels possess the biochemical signature of tissue-specific ECM and have the potential for clinical translation. Gels from decellularized porcine small intestine (SI) mucosa/submucosa enable formation and growth of endoderm-derived human organoids, such as gastric, hepatic, pancreatic, and SI. ECM gels can be used as a tool for direct human organoid derivation, for cell growth with a stable transcriptomic signature, and for in vivo organoid delivery. The development of these ECM-derived hydrogels opens up the potential for human organoids to be used clinically.
Suggested Citation
Giovanni Giuseppe Giobbe & Claire Crowley & Camilla Luni & Sara Campinoti & Moustafa Khedr & Kai Kretzschmar & Martina Maria De Santis & Elisa Zambaiti & Federica Michielin & Laween Meran & Qianjiang , 2019.
"Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture,"
Nature Communications, Nature, vol. 10(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-13605-4
DOI: 10.1038/s41467-019-13605-4
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Suran Kim & Sungjin Min & Yi Sun Choi & Sung-Hyun Jo & Jae Hun Jung & Kyusun Han & Jin Kim & Soohwan An & Yong Woo Ji & Yun-Gon Kim & Seung-Woo Cho, 2022.
"Tissue extracellular matrix hydrogels as alternatives to Matrigel for culturing gastrointestinal organoids,"
Nature Communications, Nature, vol. 13(1), pages 1-21, December.
- Anna Urciuolo & Giovanni Giuseppe Giobbe & Yixiao Dong & Federica Michielin & Luca Brandolino & Michael Magnussen & Onelia Gagliano & Giulia Selmin & Valentina Scattolini & Paolo Raffa & Paola Caccin , 2023.
"Hydrogel-in-hydrogel live bioprinting for guidance and control of organoids and organotypic cultures,"
Nature Communications, Nature, vol. 14(1), pages 1-14, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-13605-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.